Research Article
Effect of Topical Nepafenac on Central Foveal Thickness following Panretinal Photocoagulation in Diabetic Patients
Table 1
Baseline characteristics of studied patients.
| | Nepafenac group () | Control group () | value |
| Age (years) mean ± SD | 47.6 ± 6.3 | 46.4 ± 5.6 | 0.91 | Female sex, n (%) | 16 (53.3%) | 18 (60%) | 0.89 | Type of diabetes, n (%) | Type I | 11 (36.7%) | 10 (33.3%) | 0.82 | Type II | 16 (53.3%) | 18 (60%) | Uncertain | 3 (10%) | 2 (6.7%) | Duration of diabetes (years) mean ± SD | 9.3 ± 2.9 | 9.5 ± 2.7 | 0.87 | Hypertension, n (%) | 18 (60%) | 17 (56.7%) | 1.00 | HBA1c (%) mean ± SD | 8.1 ± 1.1 | 8.2 ± 1.2 | 0.88 | Type of diabetic retinopathy | | Severe NPDR | 9 eyes (30%) | 11 eyes (36.7%) | 0.87 | PDR | 21 eyes (70%) | 19 eyes (63.3%) | 0.89 |
|
|
NPDR: nonproliferative diabetic retinopathy; PDR: proliferative diabetic retinopathy; SD: standard deviation.
|